Early Access: CaroRhythm

Happy Monday and welcome back to Early Access by Coeus Collective Ventures: the newsletter where we do the sourcing and you get the deal.

Last week, we explored RIFT, a deep-tech startup building a location infrastructure that is designed to work where traditional GPS and camera vision fail. Today, we’re shifting our focus to CaroRhythm, a med-tech startup building a wearable device to improve stroke care beyond the hospital.

This is a potentially life-saving technology. Let’s explore CaroRhythm.

Despite all of modern medicine’s advances, stroke care is still largely reactive. We wait for something catastrophic to happen, then rush to intervene. By the time symptoms are noticeable (i.e. slurred speech, facial droop, or sudden weakness), the clock is already ticking. The therapeutic window for both pharmacological and surgical interventions is extremely narrow, often as little as six hours, with irreversible neuronal loss increasing each minute.

This boils down to a stark reality: one in four stroke survivors will have another stroke. So, for the millions of survivors living with elevated risk, that means constant uncertainty and no real-time visibility into their own condition.

CaroRhythm is changing that. They are building a wearable, non-invasive device designed specifically for stroke survivors and high-risk patients. The device is worn comfortably outside of the hospital, continuously monitoring physiological signals and applying proprietary algorithms to calculate individualized stroke risk in real time. When risk thresholds are crossed, patients receive an alert, giving them time to seek care before symptoms escalate.

By turning stroke risk into a measurable, trackable signal, CaroRhythm aims to reduce recurrence rates, accelerate intervention, and ultimately prevent irreversible neurological damage.